Chlorophyll (Chlorophyllin) and aflatoxin exposure

What 2 graded rows on chlorophyll (chlorophyllin) agree on for aflatoxin exposure, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Chlorophyll (Chlorophyllin) page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Chlorophyll (Chlorophyllin) page, with its PubMed record.

Supplement

Chlorophyll (Chlorophyllin) Choose another

2 rows · 183 people

They agree: both rows found an improvement.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

The best-graded row, grade C, is a randomized trial of 180 people (2001) and found an improvement.

The rows run from 3 to 180 people, published from 2001 to 2009: 2 single studies.

2 improved

Grade CUrinary aflatoxin-DNA adducts (biomarker of liver cancer risk) · Improved
RCT · n 180 · 2001 · Healthy adults in Qidong, China, with unavoidable dietary aflatoxin exposure
100 mg three times daily with meals · 4 months
Median urinary aflatoxin-N7-guanine was 55% lower than placebo at 3 months (p=0.036); adherence was high and no adverse events were reported.
Row on the Chlorophyll (Chlorophyllin) page · PubMed 11724948 (opens PubMed)
Grade DAflatoxin absorption from a tracer dose · Improved
PK study · n 3 · 2009 · Healthy volunteers (US) given a microdose of radiolabelled aflatoxin B1
150 mg with the aflatoxin dose · Single doses, repeated three times per volunteer
Both chlorophyll and chlorophyllin impeded aflatoxin absorption and lowered blood and urine exposure in one or more subjects.
Row on the Chlorophyll (Chlorophyllin) page · PubMed 19952359 (opens PubMed)